Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 212 of the 213 references it cites were found in a registry or an index.

Harnessing innate immunity in cancer therapy

Abstract

New therapies that promote antitumour immunity have been recently developed. Most of these immunomodulatory approaches have focused on enhancing T-cell responses, either by targeting inhibitory pathways with immune checkpoint inhibitors, or by targeting activating pathways, as with chimeric antigen receptor T cells or bispecific antibodies. Although these therapies have led to unprecedented successes, only a minority of patients with cancer benefit from these treatments, highlighting the need to identify new cells and molecules that could be exploited in the next generation of immunotherapy. Given the crucial role of innate immune responses in immunity, harnessing these responses opens up new possibilities for long-lasting, multilayered tumour control.

Overview

Integrity signals

Registry

Crossref · 10.1038/s41586-019-1593-5

Cites

212 of 212 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 213 references

Cited by

See all 1,000

Metadata

Authors
Demaria, O., Cornen, S., Daëron, M., Morel, Y., Medzhitov, R., & Vivier, E.
Affiliations
  • Innate Pharma (France) (FR)
  • Centre National de la Recherche Scientifique (FR)
  • Howard Hughes Medical Institute (US)
Venue
Nature
Published
2019-10-02
Volume
574
Issue
7776
Pages
45-56
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W2977255036
Cited by
957
References
213
Citations by year
2026: 72 · 2025: 159 · 2024: 186 · 2023: 178 · 2022: 134 · 2021: 132 · 2020: 86 · 2019: 9
FWCI
7.85
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Nature (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
Funders
Agence Nationale de la Recherche (ANR-17-RHUS-0007)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
  • Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Keywords
innate immunity, antitumor immunity, cancer immunotherapy, innate immune cells, natural killer cells, dendritic cells, macrophages, tumour-associated macrophages, T cell response, chimeric antigen receptor T cells, bispecific antibodies, immunomodulation
MeSH terms
Animals, Humans, Immunity, Innate, Immunotherapy, Neoplasms, T-Lymphocytes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Harnessing innate immunity in cancer therapy. https://app.cochat.ai/papers/10.1038/s41586-019-1593-5
The paper
Demaria, O., Cornen, S., Daëron, M., Morel, Y., Medzhitov, R., & Vivier, E. (2019). Harnessing innate immunity in cancer therapy. Nature. https://doi.org/10.1038/s41586-019-1593-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.